Gautam Patel Transfers Shares of Amneal Pharmaceuticals Inc (AMRX) — SEC Form 4, Nov 08, 2023
SEC Form 4 · No Market Transaction
Other Transaction
Non-market transaction reported.
Equity Position
30.8M sh
13,261,751 → 30,759,087
Equity Change
+131.9%
shares held after vs before
Filing Lag
1 business day
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Gautam Patel CIK 0001738054 |
Director
10% Owner
|
Gautam Patel at Amneal Pharmaceuticals Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Amneal Pharmaceuticals Inc
| 2026-08-12 | Award | — | View |
| 2026-05-08 | Exercise | — | View |
| 2025-06-18 | Sell | -$761,146 | View |
| 2025-06-12 | Sell | -$452,537 | View |
| 2025-05-08 | Exercise | — | View |
Non-Derivative Securities Transactions
Derivative Securities Transactions
Non-Derivative Holdings
| Title | Shares Held | Ownership |
|---|---|---|
| Class A Common StockF1 | 374,318 | Direct |
Footnotes (4)
- F1
- On November 7, 2023, Amneal Pharmaceuticals, Inc. (formerly known as Amneal NewCo Inc.) (the "Issuer") became the successor of Amneal Intermediate Inc. (formerly known as Amneal Pharmaceuticals, Inc.) ("Old PubCo") pursuant to merger transactions, in which a subsidiary of the Issuer merged with and into Old PubCo with Old PubCo surviving and, immediately following such merger, a subsidiary of the Issuer merged with and into Amneal Pharmaceuticals, LLC ("AP"), an indirect subsidiary of the Issuer, with AP surviving. The transactions resulted in the Issuer becoming a parent holding company of Old PubCo and AP. As a result of the transactions, there is a single class of stock of the Issuer outstanding, and the proportionate economic and voting rights of security holders in the Issuer are identical to the direct and indirect economic and voting rights held in Old PubCo and AP prior to the transactions. Show more
- F2
- Prior to the transactions, pursuant to the terms of the limited liability company agreement for AP, limited liability common units (each unit representing a fractional part of the Reporting Person's interest in the profits, losses and distributions of AP) ("AP Units") and an equal number of shares of Class B Common Stock of Old PubCo, together were redeemable at any time for shares of Class A Common Stock of Old PubCo on a one-for-one basis at the discretion of the holder, subject to exchange rate adjustments for stock splits, stock dividends, and reclassifications. In connection with the transactions, the AP Units held by the Reporting Person were exchanged on a one-for-one basis for shares of Class A Common Stock of the Issuer, and all of the shares of Class B Common Stock of the Issuer held by the Reporting Person were surrendered to the Issuer for no consideration. Show more
- F3
- By trusts which the reporting person may be deemed to control. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. Show more
- F4
- The Issuer of the Common Units is Amneal Pharmaceuticals, LLC. Show more
Related filings at Amneal Pharmaceuticals Inc
Institutional Holders
13F holders · Jun 30, 2026
312
institutional managers reporting a position
Largest by reported value
- Black Rock, Inc. $460M
- Tpg Gp A, Llc $213M
- Vanguard Portfolio Management Llc $210M
5%+ Holders · 13D/G
6 filers
-
Chintu Patel 9.4%
-
Chirag Patel 8.4%
-
Tushar Patel 17.6%
-
Black Rock, Inc. 7.6%
-
Patel Dipan 5.4%
Other insiders at Amneal Pharmaceuticals Inc
GET /v1/forms/4/0001209191-23-054741
API docs
View Original SEC Filing